Assessment of Heart and Liver Iron Overload in Thalassemia Major Patients Using T2* Magnetic Resonance Imaging
- PMID: 28596656
- PMCID: PMC5442050
- DOI: 10.1007/s12288-016-0696-5
Assessment of Heart and Liver Iron Overload in Thalassemia Major Patients Using T2* Magnetic Resonance Imaging
Abstract
Accumulation of excess iron in heart can lead to cardiac dysfunction, which is the most common cause of death in thalassemia major patients. Biopsy is an invasive procedure and therefore not an ideal option to assess iron load. However, standard/usual non-invasive methods, such as ferritin measurement, have some limitations and the results show poor correlations with iron load. Magnetic Response Imaging (MRI-T2*), as a non-invasive and reliable method for iron load assessment in organs such as liver and heart, can be suggested as a favorable alternative. This cross-sectional study was implemented in Thalassemia and Hemophilia Clinic Center (Sarvar) affiliated with Mashhad University of Medical Sciences, Mashhad, Iran, from 2012 to 2013. After the approval of the research protocol by the local ethic committee, laboratory tests, including CBC and serum ferritin, were carried out, and echocardiography and heart and liver MRI-T2* were performed. All statistical analysis was done through SPSS software (version 11.5), using independent sample t test and Pearson's correlation coefficient test. A P value ≤0.05 was considered to be significant. 88 patients with the mean (±SD) age of 21.2 (±5.6) years, (range 11-37 years) were observed. Iron load was assessed using MRI-T2* with the following results: Out of 88 patients, 48.9 % had mild to severe cardiac siderosis, and 75.2 % had mild to severe liver siderosis. We demonstrated a correlation between liver MRI-T2* and serum ferritin, and heart MRI-T2* and ejection fraction. However, no correlation between liver and heart MRI-T2* was observed. Heart and liver siderosis is a common and serious problem in thalassemia major patients, and MRI-T2* as a sensitive and non-invasive technique can be used for early/timely detection of siderosis and good therapeutic monitoring in these patients.
Keywords: Ferritin; Heart; Iron overload; Liver; MRI; Thalassemia.
Figures

Similar articles
-
The Importance of Cardiac T2* Magnetic Resonance Imaging for Monitoring Cardiac Siderosis in Thalassemia Major Patients.Tomography. 2021 Apr 18;7(2):130-138. doi: 10.3390/tomography7020012. Tomography. 2021. PMID: 33919601 Free PMC article.
-
Serum Ferritin Levels Correlation With Heart and Liver MRI and LIC in Patients With Transfusion-Dependent Thalassemia.Iran Red Crescent Med J. 2015 Apr 25;17(4):e24959. doi: 10.5812/ircmj.17(4)2015.24959. eCollection 2015 Apr. Iran Red Crescent Med J. 2015. PMID: 26023341 Free PMC article.
-
Evaluation of iron overload by cardiac and liver T2* in β-thalassemia: Correlation with serum ferritin, heart function and liver enzymes.J Cardiovasc Thorac Res. 2021;13(1):54-60. doi: 10.34172/jcvtr.2021.18. Epub 2021 Feb 18. J Cardiovasc Thorac Res. 2021. PMID: 33815703 Free PMC article.
-
Early detection of cardiac involvement in thalassemia: From bench to bedside perspective.World J Cardiol. 2013 Aug 26;5(8):270-9. doi: 10.4330/wjc.v5.i8.270. World J Cardiol. 2013. PMID: 24009816 Free PMC article. Review.
-
Comparison of Deferiprone to Deferasirox and Deferoxamine to Cardiac and Hepatic T2* MRI in Thalassemia Patients: Evidence-based Case Report.Acta Med Indones. 2018 Apr;50(2):168-176. Acta Med Indones. 2018. PMID: 29950538 Review.
Cited by
-
Correlation between Serum Fatty Acid Binding Protein 4 (FABP4) Levels and Cardiac Function in Patients with Thalassemia Major.Dis Markers. 2021 Dec 27;2021:5130628. doi: 10.1155/2021/5130628. eCollection 2021. Dis Markers. 2021. PMID: 34987673 Free PMC article.
-
Evaluation of the efficacy of signal-averaged electrocardiogram testing in the cardiac assessment of beta-thalassemia major patients.BMC Cardiovasc Disord. 2022 Dec 7;22(1):534. doi: 10.1186/s12872-022-02984-0. BMC Cardiovasc Disord. 2022. PMID: 36476577 Free PMC article.
-
Left ventricular deformation mechanics over time in patients with thalassemia major with and without iron overload.BMC Cardiovasc Disord. 2021 Feb 9;21(1):81. doi: 10.1186/s12872-021-01897-8. BMC Cardiovasc Disord. 2021. PMID: 33563223 Free PMC article.
-
Left Ventricular Myocardial Dysfunction Evaluation in Thalassemia Patients Using Echocardiographic Radiomic Features and Machine Learning Algorithms.J Digit Imaging. 2023 Dec;36(6):2494-2506. doi: 10.1007/s10278-023-00891-0. Epub 2023 Sep 21. J Digit Imaging. 2023. PMID: 37735309 Free PMC article.
-
Magnetic resonance imaging during management of patients with transfusion-dependent thalassemia: a single-center experience.Radiol Med. 2018 Aug;123(8):572-576. doi: 10.1007/s11547-018-0889-0. Epub 2018 Apr 16. Radiol Med. 2018. PMID: 29663188
References
-
- Keramati MR, Sadeghian MH, Ayatillahi H, Younes Y. Screening of hemoglobin disorders in referral cases to the hospital’s laboratory in northeast Iran. Int J Hematol Oncol. 2013;23(2):138–142. doi: 10.4999/uhod.11046. - DOI
-
- Borgna-Pignatti C, Galanello R. Thalassemias and related disorders: quantitative disorders of hemoglobin synthesis. In: Wintrobe MM, Greer JP, editors. Wintrobe’s clinical hematology. 12. Philadelphia: Lippincott Williams & Wilkins; 2009. pp. 1336–1342.
-
- Telfer PT, Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B. Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol. 2000;110(4):971–977. doi: 10.1046/j.1365-2141.2000.02298.x. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources